MedPath

Effect of granulocyte colony stimulating factor in ART treatment

Phase 3
Conditions
Infertility.
Complication associated with artificial fertilization, unspecified
N98.9
Registration Number
IRCT201508236420N13
Lead Sponsor
Vice Chancellor for research of Shahid Sadoughi University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

infertile women
candidate for IVF
normal endometrial thickness
age18-40 years old

Exclusion Criteria

repeated implantation failure
endocrine disorders
severe endometriosis
congenital or acquired uterine anomaly
renal disease
sickle cell disease
malignancy history
upper respiratory tract infection
pneumonia
chronic neutropenia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: serum ßhCG.
Secondary Outcome Measures
NameTimeMethod
Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: sonography.;Abortion. Timepoint: 18 weeks after embryo transfer. Method of measurement: sonography.;Clinical pregnancy. Timepoint: 3 weeks after positive BHCG. Method of measurement: sonography.;Implantation. Timepoint: 3 weeks after positive BHCG. Method of measurement: assessed by the number of gestational sacs per number of transferred embryos.
© Copyright 2025. All Rights Reserved by MedPath